Stock listing
Nkgen Biotech Inc.
Selected listing: NKGN · OTC · USD · US
Nkgen Biotech Inc. (OTC:NKGN), Finance. Latest release Sep 15, 2026: NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay…
- Ticker
- OTC:NKGN
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- OTC
- Currency
- USD
About Nkgen Biotech Inc.
Nkgen Biotech Inc. is a public company traded under the ticker NKGN on the American market. The company is committed to advancing its research and development efforts in the biotech sector.
Latest news from Nkgen Biotech Inc.
NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum
September 15, 2026
NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026
September 10, 2026
NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
April 9, 2026
NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™
March 23, 2026
NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board
January 22, 2026